{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:40:46Z","timestamp":1786984846712,"version":"build-2736575974"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82003557"],"award-info":[{"award-number":["82003557"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81773547"],"award-info":[{"award-number":["81773547"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.atherosclerosis.2020.12.005","type":"journal-article","created":{"date-parts":[[2020,12,8]],"date-time":"2020-12-08T05:47:00Z","timestamp":1607406420000},"page":"112-121","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Exploring the causal pathway from bilirubin to CVD and diabetes in the UK biobank cohort study: Observational findings and Mendelian randomization studies"],"prefix":"10.1016","volume":"320","author":[{"given":"Lei","family":"Hou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongkai","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shucheng","family":"Si","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoru","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinhui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0717-5420","authenticated-orcid":false,"given":"Fan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0378-7956","authenticated-orcid":false,"given":"Fuzhong","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2020.12.005_bib1","doi-asserted-by":"crossref","first-page":"F629","DOI":"10.1152\/ajprenal.00213.2009","article-title":"GEC-targeted HO-1 expression reduces proteinuria in glomerular immune injury","volume":"297","author":"Duann","year":"2009","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.atherosclerosis.2020.12.005_bib2","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2174\/156652307780363134","article-title":"Heme oxygenase -1 gene therapy: recent advances and therapeutic applications","volume":"7","author":"Abraham","year":"2007","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.atherosclerosis.2020.12.005_bib3","doi-asserted-by":"crossref","first-page":"16093","DOI":"10.1073\/pnas.252626999","article-title":"Biliverdin reductase: a major physiologic cytoprotectant","volume":"99","author":"Baranano","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.atherosclerosis.2020.12.005_bib4","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1126\/science.3029864","article-title":"Bilirubin is an antioxidant of possible physiological importance","volume":"235","author":"Stocker","year":"1987","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2020.12.005_bib5","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1161\/ATVBAHA.114.304929","article-title":"Circulating total bilirubin and risk of incident cardiovascular disease in the general population [J]","volume":"35","author":"Kunutsor","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"10","key":"10.1016\/j.atherosclerosis.2020.12.005_bib6","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/S0002-9149(01)01494-1","article-title":"Total serum bilirubin and risk of cardiovascular disease in the Framingham offspring study","volume":"87","author":"Djouss\u00e9","year":"2001","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2020.12.005_bib7","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0021-9150(00)00420-2","article-title":"Association of plasma bilirubin with coronary heart disease and segregation of bilirubin as a major gene trait: the NHLBI family heart study","volume":"154","author":"Hunt","year":"2001","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2020.12.005_bib8","doi-asserted-by":"crossref","first-page":"3422","DOI":"10.1161\/STROKEAHA.109.560649","article-title":"Low serum bilirubin level as an independent predictor of stroke incidence: a prospective study in Korean men and women","volume":"40","author":"Kimm","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.atherosclerosis.2020.12.005_bib9","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1161\/CIRCULATIONAHA.112.114066","article-title":"Cardiovascular events as a function of serum bilirubin levels in a large, statin-treated cohort","volume":"126","author":"Horsfall","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2020.12.005_bib10","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1161\/01.ATV.16.2.250","article-title":"Higher serum bilirubin is associated with decreased risk for early familial coronary artery disease","volume":"16","author":"Hopkins","year":"1996","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2020.12.005_bib11","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/clinchem\/40.1.18","article-title":"Association of low serum concentration of bilirubin with increased risk of coronary artery disease","volume":"40","author":"Schwertner","year":"1994","journal-title":"Clin. Chem."},{"key":"10.1016\/j.atherosclerosis.2020.12.005_bib12","doi-asserted-by":"crossref","first-page":"23\u201028","DOI":"10.1016\/j.diabres.2019.04.033","article-title":"Association between serum total bilirubin levels and the risk of type 2 diabetes mellitus","volume":"152","author":"Yang","year":"2019","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.atherosclerosis.2020.12.005_bib16","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1161\/CIRCULATIONAHA.106.633206","article-title":"Association between the UGT1A1*28 allele, bilirubin levels, and coronary heart disease in the Framingham Heart Study","volume":"114","author":"Lin","year":"2006","journal-title":"Circulation"},{"issue":"13","key":"10.1016\/j.atherosclerosis.2020.12.005_bib18","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1001\/jamainternmed.2013.6465","article-title":"Extreme bilirubin levels as a causal risk factor for symptomatic gallstone disease","volume":"173","author":"Stender","year":"2013","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.atherosclerosis.2020.12.005_bib19","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1365-2796.2012.02576.x","article-title":"Genetically elevated bilirubin and risk of ischaemic heart disease: three Mendelian randomization studies and a meta-analysis","volume":"273","author":"Stender","year":"2013","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.atherosclerosis.2020.12.005_bib21","article-title":"Circulating total bilirubin and risk of non-alcoholic fatty liver disease in the PREVEND study: observational findings and a Mendelian randomization study [published online ahead of print, 2019 Nov 26]","author":"Kunutsor","year":"2019","journal-title":"Eur. J. Epidemiol."},{"issue":"11","key":"10.1016\/j.atherosclerosis.2020.12.005_bib22","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.006503","article-title":"Circulating total bilirubin and future risk of hypertension in the general population: the prevention of renal and vascular end-stage disease (PREVEND) prospective study and a mendelian randomization approach","volume":"6","author":"Kunutsor","year":"2017","journal-title":"J. Am. Heart Assoc."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2020.12.005_bib23","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1530\/EC-15-0087","article-title":"Mendelian randomization studies of biomarkers and type 2 diabetes","volume":"4","author":"Abbasi","year":"2015","journal-title":"Endocr. Connect"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2020.12.005_bib24","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.2337\/db14-0228","article-title":"Bilirubin as a potential causal factor in type 2 diabetes risk: a Mendelian randomization study","volume":"64","author":"Abbasi","year":"2015","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2020.12.005_bib25","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1161\/ATVBAHA.119.313055","article-title":"Causal Associations Between Serum Bilirubin Levels and Decreased Stroke Risk: a Two-Sample Mendelian Randomization Study [published correction appears in Arterioscler Thromb Vasc Biol. 2020 Apr;40(4):e118]","volume":"40","author":"Choi","year":"2020","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2020.12.005_bib26","doi-asserted-by":"crossref","DOI":"10.4178\/epih.e2019034","article-title":"Bilirubin and risk of ischemic heart disease in Korea: a two-sample Mendelian randomization study","volume":"41","author":"Jeon","year":"2019","journal-title":"Epidemiol. Health"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2020.12.005_bib27","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1161\/STROKEAHA.116.015083","article-title":"Bilirubin and stroke risk using a mendelian randomization design","volume":"48","author":"Lee","year":"2017","journal-title":"Stroke"},{"key":"10.1016\/j.atherosclerosis.2020.12.005_bib30","doi-asserted-by":"crossref","first-page":"662","DOI":"10.3389\/fgene.2018.00662","article-title":"Genetically regulated bilirubin and risk of non-alcoholic fatty liver disease: a mendelian randomization study","volume":"9","author":"Luo","year":"2018","journal-title":"Front. Genet."},{"key":"10.1016\/j.atherosclerosis.2020.12.005_bib31","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.exger.2015.09.014","article-title":"Serum total bilirubin levels and coronary heart disease--Causal association or epiphenomenon?","volume":"72","author":"Kunutsor","year":"2015","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.atherosclerosis.2020.12.005_bib34","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41586-018-0579-z","article-title":"The UK Biobank resource with deep phenotyping and genomic data","volume":"562","author":"Bycroft","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2020.12.005_bib35","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.34408","article-title":"The MR-Base Collaboration. The MR-Base platform supports systematic causal inference across the human phenome","volume":"7","author":"Hemani","year":"2018","journal-title":"eLife"},{"key":"10.1016\/j.atherosclerosis.2020.12.005_bib41","article-title":"E-values for Mendelian Randomization [published online ahead of print, 2020 Jan 27]","author":"Swanson","year":"2020","journal-title":"Epidemiology"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2020.12.005_bib37","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1177\/0962280215597579","article-title":"A review of instrumental variable estimators for Mendelian randomization","volume":"26","author":"Burgess","year":"2017","journal-title":"Stat. Methods Med. Res."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2020.12.005_bib39","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1038\/s41467-020-14452-4","article-title":"Exploiting horizontal pleiotropy to search for causal pathways within a Mendelian randomization framework","volume":"11","author":"Cho","year":"2020","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2020.12.005_bib40","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1093\/ije\/dyy101","article-title":"Improving the visualization, interpretation and analysis of two-sample summary data Mendelian randomization via the Radial plot and Radial regression [published correction appears in Int J Epidemiol. 2018 Dec 1;47(6):2100]","volume":"47","author":"Bowden","year":"2018","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.atherosclerosis.2020.12.005_bib32","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1471-2261-12-16","article-title":"Association between bilirubin and cardiovascular disease risk factors: using Mendelian randomization to assess causal inference","volume":"12","author":"McArdle","year":"2012","journal-title":"BMC Cardiovasc. Disord."},{"key":"10.1016\/j.atherosclerosis.2020.12.005_bib42","first-page":"55","article-title":"The role of bilirubin in diabetes, metabolic syndrome, and cardiovascular diseases","volume":"3","year":"2012","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.atherosclerosis.2020.12.005_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2008.01.001","article-title":"Gilbert syndrome, UGT1A1*28 allele, and cardiovascular disease risk: possible protective effects and therapeutic applications of bilirubin","volume":"198","author":"Schwertner","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2020.12.005_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-2423(06)43001-8","article-title":"The heme catabolic pathway and its protective effects on oxidative stress-mediated diseases","volume":"43","author":"V\u00edtek","year":"2007","journal-title":"Adv. Clin. Chem."},{"key":"10.1016\/j.atherosclerosis.2020.12.005_bib49","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/dmrr.635","article-title":"Impact of diabetes mellitus on the relationships between iron-, inflammatory- and oxidative stress status","volume":"22","author":"Van Campenhout","year":"2006","journal-title":"Diabetes Metab. Res. Rev."},{"key":"10.1016\/j.atherosclerosis.2020.12.005_bib50","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.freeradbiomed.2005.04.030","article-title":"Diabetes, glucose toxicity, and oxidative stress: a case of double jeopardy for the pancreatic islet beta cell","volume":"41","author":"Robertson","year":"2006","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.atherosclerosis.2020.12.005_bib51","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1161\/CIRCULATIONAHA.112.147082","article-title":"The gold within","volume":"126","author":"Seppen","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2020.12.005_bib52","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1172\/JCI25102","article-title":"Inflammation, stress, and diabetes","volume":"115","author":"Wellen","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.atherosclerosis.2020.12.005_bib53","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1042\/BST0360930","article-title":"The sensitivity of pancreatic beta-cells to mitochondrial injuries triggered by lipotoxicity and oxidative stress","volume":"36","author":"Li","year":"2008","journal-title":"Biochem. Soc. Trans."},{"issue":"Suppl 5","key":"10.1016\/j.atherosclerosis.2020.12.005_bib54","first-page":"243","article-title":"[Role of advanced glycation end products (AGE) and soluble receptor for AGE (sRAGE) in vascular complications in diabetes]","volume":"70","author":"Yamagishi","year":"2012","journal-title":"Nihon Rinsho"},{"key":"10.1016\/j.atherosclerosis.2020.12.005_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2337\/diabetes.48.1.1","article-title":"Role of oxidative stress in diabetic complications: a new perspective on an old paradigm","volume":"48","author":"Baynes","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.atherosclerosis.2020.12.005_bib56","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/35041687","article-title":"Oxidants, oxidative stress and the biology of ageing","volume":"408","author":"Finkel","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2020.12.005_bib58","doi-asserted-by":"crossref","DOI":"10.2337\/db13-1652","article-title":"Bilirubin and progression of nephropathy in type 2 diabetes: a post-hoc analysis of renaal with independent replication in idnt","author":"Riphagen","year":"2014","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2020.12.005_bib47","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/01.hjr.0000230097.81202.9f","article-title":"Bilirubin and coronary heart disease risk in the prospective epidemiological study of myocardial infarction (PRIME)","volume":"14","author":"Troughton","year":"2007","journal-title":"Eur. J. Cardiovasc. Prev. Rehabil."},{"key":"10.1016\/j.atherosclerosis.2020.12.005_bib48","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1093\/clinchem\/41.10.1504","article-title":"Serum bilirubin and risk of ischemic heart disease in middle-aged British men","volume":"41","author":"Breimer","year":"1995","journal-title":"Clin. Chem."},{"key":"10.1016\/j.atherosclerosis.2020.12.005_bib59","article-title":"Effect of bilirubin concentration on the risk of diabetic complications: a meta-analysis of epidemiologic studies","volume":"7","author":"Zhu","year":"2017","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2020.12.005_bib59a","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.aohep.2019.02.001","article-title":"Association between plasma bilirubin and mortality","volume":"18","author":"Vitek","year":"2019","journal-title":"Ann. Hepatol."},{"issue":"11","key":"10.1016\/j.atherosclerosis.2020.12.005_bib60","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1136\/thoraxjnl-2020-214756","article-title":"Genetically raised serum bilirubin levels and lung cancer: a cohort study and Mendelian randomisation using UK Biobank","volume":"75","author":"Horsfall","year":"2020","journal-title":"Thorax"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2020.12.005_bib61","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1515\/cclm-2017-0692","article-title":"The UGT1A1*28 gene variant predicts long-term mortality in patients undergoing coronary angiography","volume":"56","author":"Zulus","year":"2018","journal-title":"Clin. Chem. Lab. Med."},{"issue":"136","key":"10.1016\/j.atherosclerosis.2020.12.005_bib62","article-title":"Serum bilirubin concentration is modified by UGT1A1 haplotypes and influences risk of type-2 diabetes in the Norfolk Island genetic isolate","volume":"16","author":"Benton","year":"2015","journal-title":"BMC Genet."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2020.12.005_bib63","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.atherosclerosis.2013.04.008","article-title":"Association of SNPs in the UGT1A gene cluster with total bilirubin and mortality in the Diabetes Heart Study","volume":"229","author":"Cox","year":"2013","journal-title":"Atherosclerosis"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2020.12.005_bib64","doi-asserted-by":"crossref","first-page":"567","DOI":"10.2215\/CJN.06130710","article-title":"Serum bilirubin links UGT1A1*28 polymorphism and predicts long-term cardiovascular events and mortality in chronic hemodialysis patients","volume":"6","author":"Chen","year":"2011","journal-title":"Clin. J. Am. Soc. Nephrol.: CJASN"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2020.12.005_bib65","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1159\/000319778","article-title":"Bilirubin and UGT1A1*28 are not associated with lower risk for ischemic stroke in a prospective nested case-referent setting","volume":"30","author":"Ekblom","year":"2010","journal-title":"Cerebrovasc. Dis (Basel, Switzerland)"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2020.12.005_bib66","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1161\/CIRCGENETICS.109.861773","article-title":"Plasma bilirubin and UGT1A1*28 are not protective factors against first-time myocardial infarction in a prospective, nested case-referent setting","volume":"3","author":"Ekblom","year":"2010","journal-title":"Circ. Cardiovasc. Genet."},{"issue":"14","key":"10.1016\/j.atherosclerosis.2020.12.005_bib67","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1093\/hmg\/ddp202","article-title":"Genome-wide association meta-analysis for total serum bilirubin levels","volume":"18","author":"Johnson","year":"2009","journal-title":"Hum. Mol. Genet"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2020.12.005_bib68","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.exger.2008.08.047","article-title":"Serum bilirubin levels, UGT1A1 polymorphisms and risk for coronary artery disease","volume":"43","author":"Lingenhel","year":"2008","journal-title":"Exp. Gerontol."},{"issue":"5","key":"10.1016\/j.atherosclerosis.2020.12.005_bib69","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1373\/clinchem.2007.102046","article-title":"Association between the UGT1A1 TA-repeat polymorphism and bilirubin concentration in patients with intermittent claudication: results from the CAVASIC study","volume":"54","author":"Rantner","year":"2008","journal-title":"Clin. Chem."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2020.12.005_bib70","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/0006-2952(95)02395-X","article-title":"Antioxidation of human low density lipoprotein by unconjugated and conjugated bilirubins","volume":"51","author":"Wu","year":"1996","journal-title":"Biochem. Pharmacol."},{"issue":"825","key":"10.1016\/j.atherosclerosis.2020.12.005_bib71","article-title":"Heme catabolic pathway in inflammation and immune disorders","volume":"10","author":"Wu","year":"2019","journal-title":"Front. Pharmacol."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915020315665?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915020315665?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T16:25:59Z","timestamp":1762187159000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915020315665"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":59,"alternative-id":["S0021915020315665"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2020.12.005","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring the causal pathway from bilirubin to CVD and diabetes in the UK biobank cohort study: Observational findings and Mendelian randomization studies","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2020.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}